157 related articles for article (PubMed ID: 17363179)
1. Can botulinum toxin put the restless legs syndrome to rest?
Lim EC; Seet RC
Med Hypotheses; 2007; 69(3):497-501. PubMed ID: 17363179
[TBL] [Abstract][Full Text] [Related]
2. [Restless-legs syndrome].
Karroum E; Konofal E; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for restless legs syndrome.
Fulda S; Wetter TC
Expert Opin Emerg Drugs; 2005 Aug; 10(3):537-52. PubMed ID: 16083328
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A.
Rotenberg JS; Canard K; Difazio M
J Clin Sleep Med; 2006 Jul; 2(3):275-8. PubMed ID: 17561538
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin, Quo Vadis?
Lim EC; Seet RC
Med Hypotheses; 2007; 69(4):718-23. PubMed ID: 17499937
[TBL] [Abstract][Full Text] [Related]
6. Restless legs syndrome: detection and management in primary care. National Heart, Lung, and Blood Institute Working Group on Restless Legs Syndrome.
Am Fam Physician; 2000 Jul; 62(1):108-14. PubMed ID: 10905782
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of idiopathic and uremic restless legs syndrome].
Trenkwalder C; Stiasny K; Oertel WH
Nervenarzt; 1996 Apr; 67(4):265-76. PubMed ID: 8684504
[TBL] [Abstract][Full Text] [Related]
8. Restless legs syndrome.
Bayard M; Avonda T; Wadzinski J
Am Fam Physician; 2008 Jul; 78(2):235-40. PubMed ID: 18697508
[TBL] [Abstract][Full Text] [Related]
9. The phantom of the night: restless legs syndrome in amputees.
Giummarra MJ; Bradshaw JL
Med Hypotheses; 2010 Jun; 74(6):968-72. PubMed ID: 20071104
[TBL] [Abstract][Full Text] [Related]
10. Restless legs syndrome: pathophysiology and the role of iron and folate.
Patrick LR
Altern Med Rev; 2007 Jun; 12(2):101-12. PubMed ID: 17604457
[TBL] [Abstract][Full Text] [Related]
11. Restless legs syndrome in 2004.
Sonka K; Kemlink D
Prague Med Rep; 2004; 105(4):337-56. PubMed ID: 15822631
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and pain.
Smith HS; Dhingra R; Ryckewaert L; Bonner D
Pain Physician; 2009; 12(6):1013-23. PubMed ID: 19935988
[TBL] [Abstract][Full Text] [Related]
13. Restless legs syndrome.
Ekbom K; Ulfberg J
J Intern Med; 2009 Nov; 266(5):419-31. PubMed ID: 19817966
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
15. [Restless legs syndrome].
Lai SC; Chen RS
Acta Neurol Taiwan; 2008 Mar; 17(1):54-65. PubMed ID: 18564830
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome. How to provide symptom relief with drug and nondrug therapies.
Paulson GW
Geriatrics; 2000 Apr; 55(4):35-8, 43-4, 47-8. PubMed ID: 10771701
[TBL] [Abstract][Full Text] [Related]
17. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
[TBL] [Abstract][Full Text] [Related]
18. Current guidelines and standards of practice for restless legs syndrome.
Hening WA
Am J Med; 2007 Jan; 120(1 Suppl 1):S22-7. PubMed ID: 17198767
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and symptom rating scale of restless legs syndrome].
Inoue Y
Brain Nerve; 2009 May; 61(5):533-8. PubMed ID: 19514513
[TBL] [Abstract][Full Text] [Related]
20. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
